Lipids abnormal and Renal cell carcinoma

Summary:

Renal cell carcinoma is found among people with Lipids abnormal, especially for people who are female, 60+ old.

The study analyzes which people have Renal cell carcinoma with Lipids abnormal. It is created by eHealthMe based on reports of 14 people who have Lipids abnormal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Lipids abnormal?

Lipids abnormal is found to be associated with 1,259 drugs and 465 conditions by eHealthMe. Check the latest studies of Lipids abnormal.

What is Renal cell carcinoma?

Renal cell carcinoma (a kidney cancer) is found to be associated with 786 drugs and 1,342 conditions by eHealthMe. Check the latest studies of Renal cell carcinoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

14 people who have Lipids Abnormal and Renal Cell Carcinoma are studied.

Would you have Renal cell carcinoma when you have Lipids abnormal?

Gender of people who have Lipids Abnormal and experienced Renal Cell Carcinoma *:

  • female: 53.85 %
  • male: 46.15 %

Age of people who have Lipids Abnormal and experienced Renal Cell Carcinoma *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 22.22 %
  • 50-59: 22.22 %
  • 60+: 55.56 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 3 people, 21.43%
  2. Type 2 Diabetes: 2 people, 14.29%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 14.29%
  4. Diabetes: 2 people, 14.29%
  5. Back Pain: 1 person, 7.14%
  6. Dementia (madness): 1 person, 7.14%
  7. Diabetes Mellitus Inadequate Control: 1 person, 7.14%
  8. Gastric Ulcer (stomach ulcer): 1 person, 7.14%
  9. Gout (uric acid crystals building up in the body): 1 person, 7.14%
  10. Weight Decreased: 1 person, 7.14%

Common drugs taken by these people *:

  1. Metformin: 4 people, 28.57%
  2. Omeprazole: 3 people, 21.43%
  3. Lipitor: 3 people, 21.43%
  4. Hydrochlorothiazide: 2 people, 14.29%
  5. Alli: 2 people, 14.29%
  6. Bisoprolol Fumarate: 2 people, 14.29%
  7. Trilipix: 2 people, 14.29%
  8. Boniva: 2 people, 14.29%
  9. Ozempic: 2 people, 14.29%
  10. Ramipril: 2 people, 14.29%

Common symptoms for these people *:

  1. Abdominal Pain: 2 people, 14.29%
  2. Defaecation Urgency (a sudden compelling urge to defecate): 2 people, 14.29%
  3. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body): 2 people, 14.29%
  4. Constipation: 2 people, 14.29%
  5. Bladder Neoplasm (bladder tumour): 2 people, 14.29%
  6. Haematuria (presence of blood in urine): 2 people, 14.29%
  7. Hepatic Enzyme Increased: 2 people, 14.29%
  8. Bladder Cancer: 2 people, 14.29%
  9. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 2 people, 14.29%
  10. Pain: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Renal cell carcinoma?

- Check whether Renal cell carcinoma is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Renal cell carcinoma:

All the conditions that are associated with Renal cell carcinoma:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Renal cell carcinoma and Lipids abnormal, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: